IGF1 and neoplasm: Among the 65 patients (60.7%) with controlled IGF-I and tumour status (IGF-I < ULN and tumour not visible or without changes), 1 (1.5%) and 7 (10.8%) presented a significant and mild to moderate impairment of QoL respectively.